{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T16:06:14Z","timestamp":1783181174337,"version":"3.54.6"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.ejphar.2021.174078","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T22:13:24Z","timestamp":1617920004000},"page":"174078","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Fatty acid synthase inhibition ameliorates diabetes induced liver injury in rodent experimental model"],"prefix":"10.1016","volume":"901","author":[{"given":"Onkar","family":"Bedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niharika","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davinder","family":"Parsad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawan","family":"Krishan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2021.174078_bib1","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s11094-017-1524-4","article-title":"The effects of solvent polarity on hypoglycemic and hypolipidemic activities of vaccinium arctostaphylos L. Unripe fruits","volume":"50","author":"Ahmadi","year":"2017","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.ejphar.2021.174078_bib2","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jceh.2018.10.004","article-title":"Molecular and pathological events involved in the pathogenesis of diabetes associated non-alcoholic fatty liver disease","volume":"9","author":"Bedi","year":"2019","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.ejphar.2021.174078_bib3","article-title":"In-vitro targeted screening and molecular docking of stilbene, quinones, and flavonoid on 3T3-L1 pre-adipocytes for anti- adipogenic actions","volume":"1\u201314","author":"Bedi","year":"2020","journal-title":"N-S Arch Pharmacol"},{"key":"10.1016\/j.ejphar.2021.174078_bib4","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00210-019-01742-y","article-title":"Investigations on acute oral toxicity studies of purpurin by application of OECD guideline 423 in rodents","volume":"393","author":"Bedi","year":"2019","journal-title":"N-S Arch Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174078_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejphar.2016.02.054","article-title":"Anti-hyperlipidemic and anti-peroxidative role of pterostilbene via Nrf2 signaling in experimental diabetes","volume":"777","author":"Bhakkiyalakshmi","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174078_bib6","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ecl.2008.06.007","article-title":"Obesity and free fatty acids","volume":"37","author":"Boden","year":"2008","journal-title":"Endocrinol. Metabol. Clin"},{"key":"10.1016\/j.ejphar.2021.174078_bib7","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/0003-2697(72)90335-1","article-title":"A methodology for analysis of tissue sulfhydryl components","volume":"46","author":"Boyne","year":"1972","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejphar.2021.174078_bib8","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.3390\/app8081249","article-title":"Effects of Lactobacillus on mice with diabetes induced by high-fat diet with streptozotocin (STZ)","volume":"8","author":"Chen","year":"2018","journal-title":"Appl. Sci."},{"key":"10.1016\/j.ejphar.2021.174078_bib9","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.freeradbiomed.2020.02.016","article-title":"17\u03b2-estradiol ameliorates lipotoxicity-induced hepatic mitochondrial oxidative stress and insulin resistance","volume":"150","author":"Galm\u00e9s-Pascual","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2021.174078_bib10","first-page":"2016","article-title":"Protective effects of celastrol on diabetic liver injury via TLR4\/MyD88\/NF-\u03baB signaling pathway in type 2 diabetic rats","author":"Han","year":"2016","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.ejphar.2021.174078_bib11","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1743-7075-8-18","article-title":"Onion peel extracts ameliorate hyperglycemia and insulin resistance in high fat diet\/streptozotocin-induced diabetic rats","volume":"8","author":"Jung","year":"2011","journal-title":"Nutr. Metab."},{"key":"10.1016\/j.ejphar.2021.174078_bib12","first-page":"448","article-title":"Study of prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT)","volume":"61","author":"Kalra","year":"2013","journal-title":"J. Assoc. Phys. India"},{"key":"10.1016\/j.ejphar.2021.174078_bib14","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.bj.2018.08.005","article-title":"The streptozotocin-high fat diet induced diabetic mouse model exhibits severe skin damage and alterations in local lipid mediators","volume":"41","author":"Leguina-Ruzzi","year":"2018","journal-title":"Biomed. J."},{"key":"10.1016\/j.ejphar.2021.174078_bib15","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2021.174078_bib16","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1126\/science.1439783","article-title":"What if Minkowski had been ageusic? An alternative angle on diabetes","volume":"258","author":"McGarry","year":"1992","journal-title":"Science (Wash. D C)"},{"key":"10.1016\/j.ejphar.2021.174078_bib17","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejphar.2021.174078_bib19","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.freeradbiomed.2016.11.037","article-title":"Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation","volume":"102","author":"Porras","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2021.174078_bib20","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(63)91500-9","article-title":"The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus","volume":"1","author":"Randle","year":"1963","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2021.174078_bib21","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1093\/jn\/123.11.1939","article-title":"AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet","volume":"123","author":"Reeves","year":"1993","journal-title":"J. Nutr."},{"key":"10.1016\/j.ejphar.2021.174078_bib23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.32725\/jab.2008.005","article-title":"Effect of pterostilbene on lipids and lipid profiles in streptozotocin\u2013nicotinamide induced type 2 diabetes mellitus","volume":"6","author":"Satheesh","year":"2008","journal-title":"J. Appl. Biomed."},{"key":"10.1016\/j.ejphar.2021.174078_bib24","doi-asserted-by":"crossref","DOI":"10.3892\/or.2015.3814","article-title":"Fatty acid synthase-positive hepatocytes and subsequent steatosis in rat livers by irinotecan","author":"Sawano","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ejphar.2021.174078_bib25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/jdi.12235","article-title":"Modeling type 2 diabetes in rats using high fat diet and streptozotocin","volume":"5","author":"Skovs\u00f8","year":"2014","journal-title":"J Diabetes Invest"},{"key":"10.1016\/j.ejphar.2021.174078_bib26","first-page":"8","article-title":"Potential impact of Paracentrotus lividus extract on diabetic rat models induced by high fat diet\/streptozotocin","volume":"77","author":"Soliman","year":"2016","journal-title":"JOBAZ"},{"key":"10.1016\/j.ejphar.2021.174078_bib27","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.phrs.2005.05.004","article-title":"Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening","volume":"52","author":"Srinivasan","year":"2005","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2021.174078_bib28","first-page":"156","article-title":"Quercetin induces apoptosis in triple-negative breast cancer cells via inhibiting fatty acid synthase and \u03b2-catenin","volume":"10","author":"Sultan","year":"2017","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.ejphar.2021.174078_bib29","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0027-5107(01)00177-4","article-title":"Preventive effects of anthraquinone food pigments on the DNA damage induced by carcinogens in Drosophila","volume":"480","author":"Takahashi","year":"2001","journal-title":"Mutat Res-Fund Mol M."},{"key":"10.1016\/j.ejphar.2021.174078_bib30","doi-asserted-by":"crossref","first-page":"734","DOI":"10.2337\/dc06-1539","article-title":"Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease","volume":"30","author":"Tolman","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejphar.2021.174078_bib31","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1210\/jc.2006-0587","article-title":"The role of insulin resistance in nonalcoholic fatty liver disease","volume":"91","author":"Utzschneider","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2021.174078_bib32","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1111\/bph.14482","article-title":"Nuciferine ameliorates hepatic steatosis in high\u2010fat diet\/streptozocin\u2010induced diabetic mice through a PPAR\u03b1\/PPAR\u03b3 coactivator\u20101\u03b1 pathway","volume":"175","author":"Zhang","year":"2018","journal-title":"Br. J. Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921002314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921002314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:47:45Z","timestamp":1757976465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299921002314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":29,"alternative-id":["S0014299921002314"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174078","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fatty acid synthase inhibition ameliorates diabetes induced liver injury in rodent experimental model","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"174078"}}